Wolf‐Karsten Hofmann
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Mesenchymal stem cell research
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 139
- Acute Myeloid Leukemia Research 85
- Chronic Myeloid Leukemia Treatments 58
-
- Retinoids in leukemia and cellular processes 17
- Co-authors
- Stefanie Dimmeler (2 shared papers)Andreas M. Zeiher (2 shared papers)Dieter Hoelzer (35 shared papers)Eckhard Thiel (28 shared papers)Oliver G. Ottmann (16 shared papers)Alice Fabarius (63 shared papers)Ralf Lehmann (1 shared paper)Claudius Teupe (1 shared paper)
- Journals
- Blood (79 papers)Annals of Hematology (19 papers)Leukemia Research (14 papers)PLoS ONE (9 papers)Experimental Hematology (8 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Wolf‐Karsten Hofmann
244 papers receiving 6.9k citations
Wolf‐Karsten Hofmann's Hit Papers
Peers
Comparison fields: 5 of 124
- Hematology 2.6k
- Genetics 1.8k
- Immunology 1.1k
- Cancer Research 712
- Rheumatology 656
Countries citing papers authored by Wolf‐Karsten Hofmann
This map shows the geographic impact of Wolf‐Karsten Hofmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolf‐Karsten Hofmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolf‐Karsten Hofmann more than expected).
Fields of papers citing papers by Wolf‐Karsten Hofmann
This network shows the impact of papers produced by Wolf‐Karsten Hofmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolf‐Karsten Hofmann. The network helps show where Wolf‐Karsten Hofmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Wolf‐Karsten Hofmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 258 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction Hit paper breakdown → | 2004 | 865 |
| 2 | 2012 | 328 | |
| 3 | 2010 | 317 | |
| 4 | 2012 | 268 | |
| 5 | 2011 | 212 | |
| 6 | 2013 | 151 | |
| 7 | 2010 | 143 | |
| 8 | 2011 | 142 | |
| 9 | 2007 | 135 | |
| 10 | 2009 | 127 | |
| 11 | 2000 | 122 | |
| 12 | 2009 | 120 | |
| 13 | 2007 | 100 | |
| 14 | 2003 | 100 | |
| 15 | 2009 | 95 | |
| 16 | 2021 | 92 | |
| 17 | 2013 | 88 | |
| 18 | 2010 | 84 | |
| 19 | Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. | 2003 | 81 |
| 20 | 2003 | 75 |
About Wolf‐Karsten Hofmann
Wolf‐Karsten Hofmann is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Public Health, Environmental and Occupational Health, having authored 258 papers that have together received 7.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (85 papers), Chronic Myeloid Leukemia Treatments (58 papers), Acute Lymphoblastic Leukemia research (36 papers), Eosinophilic Disorders and Syndromes (36 papers), Chronic Lymphocytic Leukemia Research (30 papers), Mast cells and histamine (29 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers) and Retinoids in leukemia and cellular processes (17 papers). The work is most often cited by research in Hematology (2.6k citations), Genetics (1.8k citations), Immunology (1.1k citations), Cancer Research (712 citations) and Rheumatology (656 citations). Wolf‐Karsten Hofmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stefanie Dimmeler, Andreas M. Zeiher, Dieter Hoelzer, Eckhard Thiel, Oliver G. Ottmann, Alice Fabarius, Ralf Lehmann, Claudius Teupe, Martina Britten and Nasreddin Abolmaali. Their work appears in journals such as Blood, Annals of Hematology, Leukemia Research, PLoS ONE and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.